Study uncovers how OTX2 drives aggressive childhood brain cancer

FHS
July 18, 2024
11:42 pm

In a report published in Nature Cell Biology, researchers at Baylor College of Medicine, Texas Children’s Hospital, the University of Manitoba and collaborating institutions revealed an unexpected way in which the protein OTX2 drives the progression of medulloblastoma – the most common aggressive childhood brain cancer.

Vaxcyte aims to raise $1B after sharing pneumococcal vaccine data; More layoffs at Genentech

Plus, news about Anthos, Ascendis, Royalty Pharma, Semnur, Sonoma, Atara, Feldan, Indivior, Aelis Farma and Acepodia: Vaxcyte launches $1B offering: The Sign up to read

September 5, 2024

Key questions (and answers) about the historic approval of a CRISPR-based medicine

History just happened. For the first time, a regulator has cleared a treatment using CRISPR, the gene-editing technology, for patients. The regulator is the United

November 16, 2023

The impact of unusually high temperatures in the summer of 2022 on infants’ sleep

Researchers investigated how the intense summer heat affects the sleep patterns of infants and toddlers.

June 23, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.